Home Cart Sign in  
Chemical Structure| 85233-19-8 Chemical Structure| 85233-19-8

Structure of BAPTA
CAS No.: 85233-19-8

Chemical Structure| 85233-19-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAPTA is an chelator of Ca2+ that can suppress intracellular reactive oxygen species (ROS). BAPTA is used as a neuroprotective agent.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAPTA

CAS No. :85233-19-8
Formula : C22H24N2O10
M.W : 476.43
SMILES Code : O=C(O)CN(CC(O)=O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(O)=O)CC(O)=O
MDL No. :MFCD00036255
InChI Key :FTEDXVNDVHYDQW-UHFFFAOYSA-N
Pubchem ID :104751

Safety of BAPTA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
pyramidal cells 5 mM prevented the LTP induction J Neurosci. 2001 Oct 15;21(20):8270-7
WEHI-231 (B lymphocyte cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels and its ability to induce apoptosis. Results showed WEHI-231 cells were sensitive to BAPTA i, with significant apoptosis induction. Cell Death Dis. 2023 Sep 8;14(9):600
OCI-AML-3 (acute myeloid leukemia cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels and its ability to induce apoptosis. Results showed OCI-AML-3 cells were sensitive to BAPTA i, with significant apoptosis induction. Cell Death Dis. 2023 Sep 8;14(9):600
OCI-AML-2 (acute myeloid leukemia cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels and its ability to induce apoptosis. Results showed OCI-AML-2 cells were sensitive to BAPTA i, with significant apoptosis induction. Cell Death Dis. 2023 Sep 8;14(9):600
H929 (multiple myeloma cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels and its ability to induce apoptosis. Results showed H929 cells were highly sensitive to BAPTA i, with significant apoptosis induction. Cell Death Dis. 2023 Sep 8;14(9):600
SU-DHL-4 (DLBCL cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels. Results showed BAPTA i significantly reduced MCL-1 protein levels but did not significantly induce apoptosis in SU-DHL-4 cells. Cell Death Dis. 2023 Sep 8;14(9):600
OCI-LY-1 (DLBCL cell line) 10 μM 6 h To investigate the effect of BAPTA i on MCL-1 protein levels and its ability to induce apoptosis. Results showed BAPTA i significantly reduced MCL-1 protein levels and induced apoptosis in OCI-LY-1 cells. Cell Death Dis. 2023 Sep 8;14(9):600
neuron-differentiated neural stem cells 10 μM, 20 μM, 40 μM 30 min To evaluate the protective effect of BAPTA on neuronal apoptosis caused by physical damage. Results showed that BAPTA significantly reduced the number of TUNEL-positive cells and decreased ROS levels, indicating that BAPTA effectively inhibits neuronal apoptosis and oxidative stress. CNS Neurosci Ther. 2021 Aug;27(8):919-929
rat hippocampal neurons 10 mM to inhibit the increase in intracellular Ca2+ concentration and reverse the dose-dependent inhibitory effect of D-serine on 300 μM NMDA-elicited current responses CNS Neurosci Ther. 2014 Nov;20(11):951-60
rat CA1 neurons 1 mM 5 min To investigate the effects of BAPTA derivatives on neuronal membrane currents, which induced an outward current and increased membrane conductance. J Physiol. 2000 Jan 15;522 Pt 2(Pt 2):231-46

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c female mice Spinal cord transection model Local drop application 10 mM Single dose, observed for 4 weeks To evaluate the effect of BAPTA on motor recovery after spinal cord transection. Results showed that the BAPTA group had significantly better mBBB scores and body weight recovery compared to the control group, and the number of TUNEL-positive cells was significantly reduced, indicating that BAPTA promotes motor recovery and inhibits neuronal apoptosis. CNS Neurosci Ther. 2021 Aug;27(8):919-929

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02025049 Pancreatitis Phase 2 Terminated(Slow recruitment) - Czech Republic ... More >> The University Hospital Brno, Gastroenterology Clinic Brno, Czech Republic, 62500 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.49mL

2.10mL

1.05mL

20.99mL

4.20mL

2.10mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories